Glycan Therapeutics offers innovative solutions for design, synthesis, analysis, and validation of glycosaminoglycans (GAGs) specifically heparan sulfate and chondroitin sulfate. Glycan Therapeutics activities include producing and selling research reagents, analytical and microarray services, and a drug development program.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
North Carolina
Company HQ Country:
United States
Year Founded:
2013
Main Therapeutic Focus:
Inflammation
Lead Product in Development:
Dekaparin
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
